USA Insurance
Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea
The Food and Drug Administration on Friday approved the use of Eli Lilly medicine Zepbound, already prescribed for weight loss, as a treatment for sleep apnea in obese patients.
